R Peto

Active 1971–2025

Also published as
R. Peto
40
Papers
30,333
Citations
38
h-index
40
i10-index

Citations

Citations per year for R Peto1969: 1 citations1972: 1 citations1973: 2 citations1974: 3 citations1975: 1 citations1976: 2 citations1977: 4 citations1978: 4 citations1979: 1 citations1980: 4 citations1981: 2 citations1982: 6 citations1983: 9 citations1984: 11 citations1985: 10 citations1986: 11 citations1987: 10 citations1988: 14 citations1989: 13 citations1990: 14 citations1991: 18 citations1992: 16 citations1993: 25 citations1994: 40 citations1995: 57 citations1996: 55 citations1997: 88 citations1998: 85 citations1999: 83 citations2000: 123 citations2001: 139 citations2002: 145 citations2003: 203 citations2004: 195 citations2005: 218 citations2006: 213 citations2007: 201 citations2008: 266 citations2009: 217 citations2010: 255 citations2011: 288 citations2012: 281 citations2013: 279 citations2014: 229 citations2015: 229 citations2016: 223 citations2017: 230 citations2018: 186 citations2019: 608 citations2020: 485 citations2021: 404 citations2022: 357 citations2023: 262 citations2024: 387 citations2025: 168 citations2026: 12 citations1970–1971: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,868 citing papers, 22.6% of this breakdownUnited Kingdom: 1,476 citing papers, 11.6% of this breakdownItaly: 587 citing papers, 4.6% of this breakdownCanada: 579 citing papers, 4.6% of this breakdownChina: 546 citing papers, 4.3% of this breakdownAustralia: 544 citing papers, 4.3% of this breakdownNetherlands: 511 citing papers, 4% of this breakdownGermany: 508 citing papers, 4% of this breakdownFrance: 421 citing papers, 3.3% of this breakdownSweden: 315 citing papers, 2.5% of this breakdownDenmark: 299 citing papers, 2.4% of this breakdownSwitzerland: 282 citing papers, 2.2% of this breakdown
0%22.6%Other 29.6%

Fields

  • Medicine74.6%
  • Biochemistry, Genetics and Molecular Biology14.9%
  • Nursing1.8%
  • Social Sciences1%
  • Immunology and Microbiology0.9%
  • Economics, Econometrics and Finance0.9%
  • Other5.9%

Topics

  • Lipoproteins and Cardiovascular Health10.8%
  • Diabetes, Cardiovascular Risks, and Lipoproteins5.9%
  • Cancer, Lipids, and Metabolism2.7%
  • Breast Cancer Treatment Studies2.5%
  • Blood Pressure and Hypertension Studies2%
  • Health Systems, Economic Evaluations, Quality of Life1.6%
  • Other74.5%

Coauthors

All papers

Open in search
  1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

    Authors: , , , , , , , , , , - The Lancet 2010 cited by 6,450

  2. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

    Authors: , , , , , , , , , , - The Lancet 2005 cited by 6,838

  3. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths

    Authors: , , , , , , , , - The Lancet 2007 cited by 2,343

  4. Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

    Authors: , , , , , , - American Journal of Epidemiology 1999 cited by 869

  5. Mortality from tobacco in developed countries: indirect estimation from national vital statistics

    Authors: , , , , - The Lancet 1992 cited by 1,413

  6. Representing a Problem Space: Towards a Deeper Understanding of the Practice of Instructional Leadership

    Authors: , , , - Circulation Research 1971 cited by 1,046

  7. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2008 cited by 226

  8. Get with the guidelines for cardiovascular secondary prevention: pilot results.

    Authors: , , , , - 2004 cited by 268

  9. Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , S Yusuf, R Peto, J Lewis, R Collins, P Sleight, R Collins, R Peto, S Macmahon, P Hebert, N Fiebach, K Eberlein, J Godwin, N Qizilbash, J Taylor, C Hennekens, The Dutch, Tia Study, Group, The Dutch, Tia, J Van Swieten, P Koudstaal, M Visser, Hja Schouten, J Van Gijn, J Bamford, Pag Sandercock, C Warlow, J Slattery, P Koudstaal, J Van Gijn, A Staal, H Duivenvoorden, Jgm Gerritsma, C Kraaijeveld, E Kaplan, P Meier, D Cox, H Greenberg, J Gillespie, E Dwyer, T Jeffers, J Webster, J Petrie, J Coope, T Warrender, S Macmahon, R Peto, J Cutler, R Collins, P Sorlie, J Neaton, R Abbott, J Godwin, A Dyer, J Stamler, Working Mrc, Party, Paf Jansen, Fwj Gribnau, Bpm Schulte, Efj Poels - Stroke 1993 cited by 146

  10. A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Drachman, T Johns, B Drachman, H Mertens, G Hertel, P Reuther, K Ricker, A Witte, D Cornblath, E Parry, R Lisak, N Schatz, G Matell, B Drachman, Gajdos Ph, D Elkharrat, C Chastang, S George, M Desu, E Kaplan, P Meier, R Peto, J Peto, D Cox, D Felson, J Anderson, R Hohlfeld, M Michels, K Heininger, U Besinger, K Toyka, V Fonseca, Cwh Havard, Corey Drachman, B - Journal of Neurology Neurosurgery & Psychiatry 1993 cited by 76

  11. Mortality from smoking worldwide

    Authors: , , , , , - British Medical Bulletin 1996 cited by 648

  12. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists Multicentre Randomised Trial of Cervical Cerclage

    Authors: , , , , , , , , , - BJOG An International Journal of Obstetrics & Gynaecology 1993 cited by 463

  13. Trials: the next 50 years

    Authors: , - BMJ 1998 cited by 245

  14. Analyses of Cancer Data from Three Ezetimibe Trials

    Authors: , , , , , , - New England Journal of Medicine 2008 cited by 230

  15. Survival and desferrioxamine in thalassaemia major.

    Authors: , , , , - BMJ 1982 cited by 206

  16. Clinical trial methodology

    Authors: , - Fundamentals of Clinical Psychopharmacology 2015 cited by 145

  17. The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls

    Authors: , , , , , , , , , , , - European Heart Journal 2009 cited by 123

  18. Using “Get With The Guidelines” to Improve Cardiovascular Secondary Prevention

    Authors: , , , , - The Joint Commission Journal on Quality and Safety 2003 cited by 108

  19. Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C Bulpitt, D Clement, M Deruyttere, Research Shep Cooperative, Group, B Dahl6f, L Lindholm, L Hansson, B Schersten, T Ekbom, P-O Wester, Working Mrc, Party, Working Mrc, Party, G Mancia, G Parati, G Pomidossi, G Grassi, R Casadei, A Zanchetti, S Julius, K Jamerson, T Gudbrindsson, N Schork, G Mancia, A Zanchetti, W Kannel, T Dawber, D Mcgee, On Mild To Moderate, Hypertension, A Zanchetti, D Levy, R Garrison, D Savage, W Kannel, W Castelli, M Koren, R Devereux, P Casale, D Savage, J Laragh, N Shulman, C Ford, W Hall, M Blaufox, D Simon, H Langford, L Ruilope, H-M Parving, E Hommel, J Cruickshank, J Thorp, F Zacharias, Study The, Group, /Ish Guidelines Who, Committee, P Layde, V Beral, C Kay, B Wren, D Routledge, A Zanchetti, P Sleight, W Birkenhiger - BMJ 1993 cited by 101

  20. Complex behavioural and educational interventions for nocturnal enuresis in children

    Authors: , , - Cochrane Database of Systematic Reviews 2004 cited by 76

  21. Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicholas Zdenkowski, Graham Beake, Richard Berry, Clare Boddington, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Francesca Holt, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Mariko Nakahara, Simon Read, Ewan Straiton, Hannah Taylor, John Forbes, Prudence A. Francis, Nicholas Wilcken, Marija Balić, Rupert Bartsch, Christian Fesl, Florian Fitzal, Hannes Fohler, Richard Greil, R. Jakesz, Christian Marth, Brigitte Mlineritsch, Georg Pfeiler, Christian F. Singer, Lidija Sölkner, Hebert Stöger, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Mark N. Levine, Joseph L. Pater, Kathleen I. Pritchard, Eileen Rakovitch, Dongsheng Tu, Timothy J. Whelan, Petronella G.M. Peer, I E G van Hellemond, Astrid Swinkles, S W M Lammers, Marco Venturini, Urania Dafni, Ann Brown, John Bryant, Reena S. Cecchini, Joe Costantino, James J. Dignam, Bernie Fisher, Charles E. Geyer, Soonmyung Paik, Carol Redmond, Edward H. Romond, Mylin A. Torres, Lawrence Wickerham, Norman Wolmark, Grey Yothers and 59 more - The Lancet 2025 cited by 28

  22. Second Asymptomatic Carotid Surgery Trial (ACST-2): Randomised Comparison of Carotid Artery Stenting vs Carotid Endarterectomy

    Authors: , , , , , , - 2021 cited by 24

  23. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Willi Sauerbrei, RS Gelman, Jennifer Redmond, A R Bianco, R. Arriagada, Megan Hauer, Marie Overgaard, Cunningham Mp, J. L. Hayward, M W Kissin, Owen Owen, W Jack, C Cooper, Pater Jl, Maho Ogawa, Jonathan Godwin, N. Scorpiglione, Palmer Mk, H Johansen, H. Hayat, A. Buzdar, H Muss, Hiroshi Sonoo, Diana Riley, G Brufman, M.J. Piccart-Gebhart, J Bryant, R Nissen, Hiroshi Koyama, Junji Uchino, Diana E. Parker, John L. Mace, Marion Durand, Giorgio Cocconi, Y Morishita, CF Oliveira, Comis Rl, A. Goldhirsch, M. Spielmann, JE Varhaug, Carsten Rose, J Bonte, Anthony Coates, CS McArdle, J. Price, John L. Powell, Lorella Vecchio, M. Schumacher, Mike Clarke, Antonio Nicolucci, Larry Norton, G Mathé, H Tooth, Rodrigo Huerta, Alexandra Velásquez, Norman Wolmark, NH Gordon, J. Houghton, M Baum, S. Gundersen, R H Creech, Gianni Bonadonna, D. Smith, R.J. Salmon, D.F. Hacking, R. Charles Coombes, Kathleen I. Pritchard, Y Lehingue, Jade Dignam, L. Mauriac and 127 more - 1998 cited by 2,156

  24. 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P, O' Malley, K Petrie, J Strasser, T Tuomilehto, J Williams, B, Research Shep Cooperative, Group, B Dahlof, L Lindholm, L Hansson, B Schersten, T Ekbom, P-O Wester, Working Mrc, Party, Working Mrc, Party, On Mild To Moderate, Hypertension, G Mancia, G Parati, G Pomidossi, G Grassi, R Casadei, A Zanchetti, S Julius, K Jamerson, T Gudbrandsson, N Schork, G Mancia, E O'brien, J Petrie, W Littler, M De Swiet, P Padfield, O' Malley, K Jamieson, M Altman, D Bland, M Atkins, N, R Sega, G Cesana, R Pagani, C Bravi, G Devito, M Ferrario, F Valagussa, A Libretti, G Mancia, A Zanchetti, G Chatellier, C Battaglia, J-Y Pagny, P-F Plouin, J Menard, A Zanchetti, G Rose, R Collins, R Peto, S Macmahon, P Hebert, N Fiebach, K Eberlein, J Godwin, N Qizilbash, J Taylor, C Hennekens and 120 more - Hypertension 1993 cited by 1,207